News

The Manila Times43m
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...
SHINE47m
A 'poster child' for Chinese biopharma wins US approval for new cancer therapy
The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...